glp-1 inflammation reduction and Gut Health: Addressing Metabolic Dysfunction for Physicians Beyond Weight Loss: How GLP-1

Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus

After consuming meals, GLP-1 incretin hormone is released in the gastrointestinal (GI) tract and cleaved by the DPP-IV enzyme

And growing evidence of its anti-inflammation properties, notes Scripps computational biologist and study co-principal investigator Julia Vogel, has driven increasing interest in using GLP-1 drugs to treat at least some of long COVIDs myriad symptoms, which range from brain fog and difficulty breathing to fatigue and joint pain

The breadth of bacteriophages contributing to the development of the phage-based vaccines for COVID-19: an ideal platform to design the multiplex vaccine

Firstly, metabolically, both hyperglycaemia and hyperinsulinemia are potent pro-fibrotic stimuli